BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terziroli Beretta-piccoli B, Di Bartolomeo C, Deleonardi G, Grondona AG, Silvestri T, Tesei C, Melidona L, Cerny A, Mertens J, Semmo N, Semela D, Moradpour D, Mieli-vergani G, Vergani D, Muratori L. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. Journal of Autoimmunity 2019;102:89-95. [DOI: 10.1016/j.jaut.2019.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kurtenkov O, Jakovleva J, Sergejev B, Geller J. Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy. Dis Markers 2020;2020:8881279. [PMID: 32685058 DOI: 10.1155/2020/8881279] [Reference Citation Analysis]
2 Gui H, Wang W, Li Q, Li Z, Lu J, Xie Q. Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection. Immunol Res 2021;69:81-9. [PMID: 33507492 DOI: 10.1007/s12026-021-09178-4] [Reference Citation Analysis]
3 Llovet LP, Gratacós-Ginés J, Ortiz O, Rodriguez-Tajes S, Lens S, Reverter E, Ruiz-Ortiz E, Costa J, Viñas O, Forns X, Parés A, Londoño MC. Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies. Liver Int 2020;40:558-64. [PMID: 31863722 DOI: 10.1111/liv.14332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Romano C, Tortorella O, Dalla Mora L, Di Stasio D, Sellitto A, Adinolfi LE, Marrone A. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Front Immunol 2022;13:882064. [DOI: 10.3389/fimmu.2022.882064] [Reference Citation Analysis]
5 Weber M, Padmanabhan Nair V, Bauer T, Sprinzl MF, Protzer U, Vincendeau M. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients. Cells 2021;10:774. [PMID: 33807462 DOI: 10.3390/cells10040774] [Reference Citation Analysis]
6 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 2021. [PMID: 34580437 DOI: 10.1038/s41423-021-00768-8] [Reference Citation Analysis]
7 Selmi C. Autoimmunity in 2019. Clin Rev Allergy Immunol 2020;59:275-86. [PMID: 32729069 DOI: 10.1007/s12016-020-08808-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Calise SJ, Chan EKL. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmun Rev 2020;19:102643. [PMID: 32805424 DOI: 10.1016/j.autrev.2020.102643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Tovo PA, Garazzino S, Daprà V, Alliaudi C, Silvestro E, Calvi C, Montanari P, Galliano I, Bergallo M. Chronic HCV Infection Is Associated with Overexpression of Human Endogenous Retroviruses that Persists after Drug-Induced Viral Clearance. Int J Mol Sci 2020;21:E3980. [PMID: 32492928 DOI: 10.3390/ijms21113980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhang X, Jain D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis. Hum Pathol 2022:S0046-8177(22)00164-2. [PMID: 35753409 DOI: 10.1016/j.humpath.2022.06.019] [Reference Citation Analysis]
11 Björnsson ES, Medina-Caliz I, Andrade RJ, Lucena MI. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports. Hepatol Commun 2022. [PMID: 35596597 DOI: 10.1002/hep4.1959] [Reference Citation Analysis]